International Speakers

Professor Carsten Bindslev-Jensen PhD DMSci

Professor in Allergology at University of Southern Denmark, chair of Odense Research Center for Anaphylaxis, and chair of the Department of Dermatology and Allergy Center in Odense, Denmark.

Professor Carsten Bindslev-Jensen graduated from the University of Copenhagen. He obtained his PhD in 1985 and his DMSci in 1988. He is author of more than 250 papers in international journals. His scientific fields of interest include food allergy, drug allergy and anaphylaxis in children and adults. He has been chair of the Danish Society for Allergology and is currently chair of Dermatology Section of the European Academy for Allergy and Clinical Immunology. Professor Bindsley-Jenson is a fellow of AAAAI.


Professor Lene Heise Garvey MB CHB PhD

 Co-founder and chief physician of the Danish Anaesthesia Allergy Centre, Denmark

Professor Lene Heise Garvey graduated in Medicine from the University of Bristol in 1994 and specialized in Anaesthesiology in Denmark in 2006. She defended her PhD on “Allergic reactions during anaesthesia and surgery” in 2010 and has since achieved a subspecialization in Allergology. She is co-founder and chief physician of the Danish Anaesthesia Allergy Centre, the National Reference Centre for investigation of perioperative hypersensitivity in Denmark, established in 1999.

Professor Garvey is a consultant in the Allergy Clinic, Herlev and Gentofte Hospitals, Denmark and shares her time between a half-time post-doc research position and seeing patients in both anaesthesia allergy and general allergy clinics. She is an active member of several task forces in the Drug Allergy Interest Group in EAACI and is currently heading a task force on perioperative hypersensitivity. Her research interests include all aspects of perioperative hypersensitivity, treatment and mechanisms of anaphylaxis, allergy to chlorhexidine and other rare allergens.


Professor Jonathan Hourihane MB BCh BAO DM

Professor of Paediatrics and Child Health in University College Cork (UCC), Ireland

Professor Jonathan Hourihane graduated from Trinity College Dublin in 1987 and undertook his higher training in Southampton and London, UK. His primary area of clinical and research interest is in paediatric food allergy and anaphylaxis. He has been Professor of Paediatrics and Child Health in University College Cork, Ireland, since 2005.

Professor Hourihane is President of the Irish Association of Allergy and Immunology, co-Principal Investigator of the BASELINE, Ireland’s only birth cohort study (www.baselinestudy.net.) and the INFANT Research Centre in UCC (www.infantcentre.ie ). He is a founding board member of the Clemens von Pirquet Foundation and the Irish Food Allergy Network (www.ifan.ie) and sits on the Board, the Scientific Committee and the Strategy Committee of the National Children’s Research Centre, Dublin.


Professor Nikos Papadopoulos MD PhD

Professor of Allergy and Paediatric Allergy at the University of Manchester, UK, Professor of Allergy and Paediatric Allergy, Head of the Allergy Department, 2nd Pediatric Clinic, University of Athens (NKUA), Greece

Professor Nikos Papadopoulos graduated from Medical School at the National and Kapodistrian University of Athens (NKUA) and received his doctorate from the Center of Immunology of Infectious Disease-AIDS, Chair of Microbiology, Medical School, NKUA. He was a Postdoctoral research fellow at the Immunology Laboratory, Hellenic Anticancer Institute, “Agios Savas” Hospital.

His main research focus is the role of infections in asthma and he has active research programs in food allergy. He has extensive collaborations and leading roles in EU projects such as EARIP, iFAAM, FAST and PreDicta. Professor Papdopoulos has published more than 250 papers, has received several international awards, and is invited to speak at international scientific meetings some 30 times a year. He has served in committees of EAACI, GA2LEN, WAO, EFA and ARIA. He was the 2013-2015 President of EAACI.


Professor Werner Joseph Pichler MD

Scientific Director of ADR-AC GmbH (Adverse Drug Reaction Analysis & Consulting), Bern, Switzerland

Professor Werner Joseph Pichler studied medicine at the University of Innsbruck, Austria and trained as an immunologist in Vienna and at the National Institutes of Health (NIH), Bethesda, USA. He became an internist and clinical immunologist by training in the Division of Clinical Immunology at the Medical School Hannover, Germany. From 1984 he worked at the University of Bern, Switzerland. He became Head of Division of Allergology and Professor for Clinical Immunology, Department of Rheumatology, Clinical Immunology & Allergology, University of Bern, retiring in 2014. He was President of the Swiss Society of Allergy and Immunology 1993-94 and in 2004 founded the biennial drug hypersensitivity meeting (DHM), now the biggest meeting worldwide on drug hypersensitivity.

Professor Pichler focused his research on drug hypersensitivity and has co-authored over 200 publications. He recently edited the book Drug Hypersensitivity and is editor of two other books on the subject. In 2006 he co-founded ADR-AC GmbH (Adverse Drug Reaction Analysis & Consulting) a company devoted to research, diagnosis and consulting on drug hypersensitivity. In 2010 he was visiting professor at the University of Adelaide and in 2015-2016 spent three months as visiting professor at Mahidol University, Bangkok.


Professor Jennifer Puck MD

Professor of Pediatrics University of California San Francisco (UCSF), USA

Earning her undergraduate and medical degrees at Harvard University and Harvard Medical School, Professor Jennifer Puck completed clinical and research training in pediatrics, infectious diseases and immunology at Washington University in St. Louis, Missouri, and Baylor College of Medicine in Houston, Texas. She joined UCSF in 2006 after serving on the faculties of the University of Pennsylvania in Philadelphia and the National Human Genome Research Institute, NIH, in Bethesda, Maryland. In addition to caring for patients as an immunologist and teaching biomedical trainees, she has a basic and translational research program that focuses on human immune disorders as well as mouse models of lymphocyte development. She has published over 185 peer reviewed research papers in addition to over 100 chapters and reviews; she is co-editor of Primary Immunodeficiencies: A Molecular and Genetic Approach, published in its 3rd edition in 2014.

Professor Puck conceived and developed a newborn screening test to detect SCID that is now widely adopted in newborn screening panels in the US and a growing number of countries. This allows infants affected with SCID and other conditions with insufficient T cells to be detected early and treated.

Professor Puck directs the UCSF Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies. She serves on the Medical Advisory Committee of the Immune Deficiency Foundation, the Committee on Primary Immunodeficiency Disease of the International Union of Immunological Societies, the Board of Scientific Councilors of NIAID, and the Steering Committees of the Primary Immune Deficiency Treatment Consortium (PIDTC) as well as the US Immunodeficiency Network (USIDNET). She has been elected to the American Society of Clinical Investigation (ASCI), Society for Pediatric Research (SPR), Association of American Physicians (AAP), American Pediatric Society (APS) and National Academy of Medicine. She received the Abbot Award in Clinical and Diagnostic Immunology from the American Society of Microbiology in 2013 and the Colonel Harlan Sanders Award for Lifetime Achievement in Genetics from the March of Dimes in 2014.


Professor Hugh A. Sampson  MD

Kurt Hirschhorn Professor of Pediatrics and Director of the Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, USA

Professor Hugh Sampson has nearly 35 years’ experience in translational research focusing on food allergic disorders and basic immunologic mechanisms responsible for these disorders.   He received his medical degree from the State University of New York at Buffalo School of Medicine.  This was followed by a residency in Pediatrics at the Children’s Memorial Hospital and a fellowship in Allergy and Immunology at Duke University Hospital.

Professor Sampson’s research has been funded continuously by a number of grants from the National Institutes of Health (NIH) including being the Principal Investigator for the Consortium for Food Allergy Research.   He was elected to membership in the Institute of Medicine of the National Academies in 2003 for his research accomplishments.

Professor Sampson has published over 450 articles, 88 book chapters and co-edited 7 books, primarily on clinical and immunopathogenic aspects of food allergic disorders.   He is past chair of the Section on Allergy and Immunology of the American Academy of Pediatrics and the past-president of the American Academy of Allergy, Asthma and Immunology.  His presidential initiative during his tenure led to the NIAID Guidelines on the Diagnosis and Management of Food Allergy. He has served on the Editorial Board of 5 allergy journals, including 20 years on the JACI Editorial Board.  In November 2015 he stepped down as Dean for Translational Biomedical Sciences at Mount Sinai to devote 40% of his time to DBV Technologies as their Chief Scientific Officer.


Professor Scott Sicherer MD

Elliot and Roslyn Jaffe Professor of Allergy, Immunology and Pediatrics and Chief of the Division of Pediatric Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, USA

Professor Scott Sicherer’s food allergy research, funded by the National Institutes of Allergy and Infectious Diseases and Food Allergy Research and Education, include studies on: natural history, epidemiology, psychosocial issues, modalities to educate physicians and parents, genetics and treatment modalities. He has published over 200 articles in scientific journals, and has authored over 50 book chapters.

He is past chair of the Adverse Reactions to Foods Committee of the Academy of Allergy, Asthma, and Immunology, of the Section on Allergy and Immunology of the American Academy of Pediatrics, and of the American Board of Allergy and Immunology. He is associate editor of the Journal of Allergy and Clinical Immunology, In Practice. He has authored four food allergy books for the lay public. Professor Sicherer has been recognized by Thompson Reuters for being among the top 1% of researchers for most cited documents in their specific field.


Basten Orator
Dr Penny Fitzharris MBChB MD FRACP FRCP

Penny Fitzharris is a University of Otago graduate, with clinical training in Dunedin and Christchurch. Her postgraduate training in Clinical Immunology and Allergy began in Christchurch and continued in London with a laboratory based MD at University College and University College Hospital.  Penny was subsequently awarded a lecturer post at the Cardiothoracic Institute and Brompton Hospital where she worked for five years in lab and clinical roles.  She was then appointed as a Consultant at St Mary’s Hospital.

After 16 years in London Penny returned to New Zealand to the Wellington School of Medicine and Capital and Coast DHB as the first Clinical Immunologist in Wellington, for eight years.  Since a further period back in London at Guy’s Hospital she has worked in Auckland Hospital for the past 12 years, with a number of years as Clinical Director of the regional service.

Her early research interests were in natural killing and its dysfunction in SLE.  More recently these have focused on varied aspects of initiation and maintenance of allergic disease, with a productive relationship with the Wellington Asthma Research group, and, clinically, on all aspects of allergy, particularly anaphylaxis and drug allergy.

She feels privileged to have worked with such excellent mentors, colleagues and trainees in a number of different areas and services.

Penny Fitzharris will present the following 2017 Basten Oration: The changing faces of Clinical Immunology and Allergy.